Labcorp (LH) Stock Forecast & Price Target

Labcorp
Bull Case

Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:

• Laboratory Co. of America Holdings recently reported second-quarter 2026 earnings that exceeded analyst expectations, delivering $4.99 in earnings per share compared to the consensus estimate of $4.78, while revenue of $3.73 billion also surpassed the projected $3.71 billion, demonstrating strong operational performance and the ability to outperform market forecasts.
• The company has maintained a consistent track record of beating earnings estimates over the last four quarters, including a $0.16 beat in the first quarter of 2026 and a $0.12 beat in the fourth quarter of 2025, which signals reliable execution and management effectiveness in delivering shareholder value.
• Laboratory Co. of America Holdings has raised its full-year 2026 earnings guidance to a range of $18.10 to $18.55 per share, which is above the current analyst consensus of $18.34, indicating that management expects continued growth and profitability throughout the remainder of the fiscal year.
• The stock currently trades at $311.73, which is below the average analyst price target of $337.73, suggesting that the market may be undervaluing the company relative to its projected future earnings and offering potential upside for investors.
• Institutional investors have shown increased confidence in the company, with several hedge funds and advisory firms, such as Sequoia Financial Advisors and Tidal Investments, increasing their stakes in the second quarter of 2026, reflecting a broader trend of professional capital flowing into the stock.